5th Annual SAS Healthcare & Life Sciences Executive Conference
Transforming Healthcare Through Patient-Centric Insights
- Andrew C. von Eschenbach, MD
- John D. Halamka, MD, MS
- Jim Davis
- Jim Goodnight
- Robert J. Greczyn Jr.
- Chris A. Viehbacher
- Robert R. Waller, MD
KEYNOTE SPEAKERS
Andrew C. von Eschenbach, MD
Commissioner of the Food and Drug Administration
Andrew C. von Eschenbach, MD, is the Commissioner of the US Food and Drug Administration and was formerly the Director of the National Cancer Institute (NCI). Dr. von Eschenbach was President-elect of the American Cancer Society at the time of his appointment to NCI. A nationally recognized urologic surgeon and oncologist, Dr. von Eschenbach previously served as Executive Vice President and Chief Academic Officer of the University of Texas M.D. Anderson Cancer Center in Houston, and held the Roy M. and Phyllis Gough Huffington Clinical Research Distinguished Chair in Urologic Oncology. Himself a cancer survivor, Dr. von Eschenbach’s contributions to scientific literature include more than 200 articles, books and book chapters.
Many influential organizations have recognized his leadership and accomplishments, including the American Medical Writers Association, the American Urological Association, the Lance Armstrong Foundation, the American Radium Society and the Best Doctors in America publication. In 2006, Time magazine chose Dr. von Eschenbach as one of the 100 most influential people to shape the world.
A native of Philadelphia, Dr. von Eschenbach earned his medical degree from Georgetown University School of Medicine. After completing his residency in urologic surgery at Pennsylvania Hospital in Philadelphia, he was an instructor in urology at the University of Pennsylvania School of Medicine. He also served as a Lieutenant Commander in the US Navy Medical Corps.
John D. Halamka, MD, MS
CIO of Harvard Medical School and Chairman of the New England Health Electronic Data Interchange Network
John D. Halamka, MD, MS, is Chief Information Officer of the CareGroup Health System, Chief Information Officer and Dean for Technology at Harvard Medical School, Chairman of the New England Health Electronic Data Interchange Network (NEHEN), Chief Executive Officer of MA-SHARE (the regional health information organization), Chair of the US Healthcare Information Technology Standards Panel (HITSP) and a practicing emergency physician.
As Chief Information Officer at CareGroup, he is responsible for all clinical, financial, administrative and academic information technology serving 3,000 doctors, 14,000 employees and 2 million patients. As Chief Information Officer and Dean for Technology at Harvard Medical School, he oversees all educational, research and administrative computing for 18,000 faculty and 3,000 students. As Chairman of NEHEN he oversees the administrative data exchange in Massachusetts. As CEO of MA-SHARE he oversees the clinical data exchange efforts in Massachusetts. And as Chair of HITSP he coordinates the process of electronic standards harmonization among stakeholders nationwide.
PANELISTS, MODERATORS AND PRESENTERS
Jim Davis
Senior Vice President and Chief Marketing Officer of SAS
Jim Davis, Senior Vice President and Chief Marketing Officer for SAS, is responsible for providing strategic direction for SAS products, solutions and services, as well as global messaging about SAS.
Upholding the company's focus to be customer-driven, Davis helped lead the transformation of SAS from a tools provider to the customer-centric software solutions provider it is today. He has built a team of strategists with industry-specific expertise who research the marketplace and partner with engineers in R&D to hone customized solutions for each industry. He has overseen a dramatic increase in SAS' profile.
Also known for his industry leadership, Davis has helped develop the Information Evolution Model, a means for companies to assess how effectively they use information to build their business. He co-authored the book Information Revolution: Using the Information Evolution Model to Grow Your Business, which outlines how organizations use and manage information as a corporate asset. The model enables organizations to evaluate their use of information objectively, providing a framework for making improvements necessary to compete in today's global arena.
Jim Goodnight
CEO of SAS
Jim Goodnight is CEO of SAS, the world's leading business intelligence software vendor. At the helm since the company's incorporation in 1976, Goodnight has overseen an unbroken chain of revenue growth – a feat almost unheard of in the software industry.
SAS® software was originally created by Goodnight and North Carolina State University colleagues to analyze agricultural-research data. Three decades later, it's doing things Goodnight never imagined in his days as a doctoral student in statistics. Today, SAS is best known for sifting massive mountains of data for FORTUNE 500® companies and other organizations most people have heard of. With its unique business model (software licensed annually) and solid reputation for innovation (24 percent of 2006 revenues reinvested in R&D), SAS is the world's largest privately owned software company.
Goodnight holds a doctorate in statistics from North Carolina State University, where he was a faculty member from 1972 to 1976. His passion for learning has since led him to endow several NCSU professorships and make education the focus of SAS' philanthropy. Goodnight has also been an active speaker and participant at the World Economic Forum, where business and world leaders discuss such cross-boundary issues as international standards, regulations and the global economy.
In 2004, Harvard Business School named Jim Goodnight one of the "20th Century's Great American Business Leaders" for his three decades of leading a business that has changed the way Americans have lived, worked and interacted in the 20th century.
Robert J. Greczyn Jr.
President and Chief Executive Officer of Blue Cross and Blue Shield of North Carolina
Bob Greczyn is President and Chief Executive Officer of Blue Cross and Blue Shield of North Carolina (BCBSNC), the state’s largest health insurer. Greczyn began his healthcare career by founding a community health center in rural Anson County, NC, a post that allowed him to make a difference in people’s lives and improve the health of his community. Now, more than 25 years later, his mission remains similar, but on the much bigger scale of 3.6 million people served by BCBSNC.
After joining the company in 1998 as Executive Vice President and Chief Operating Officer, Greczyn was named President in 1999 and became CEO in April 2000. Throughout his tenure, he has led the company’s efforts to promote healthier lifestyles and assist customers in managing chronic health conditions.
Greczyn serves on both the board of trustees for BCBSNC and on the board of the national Blue Cross and Blue Shield Association. He is immediate past Chairman of the board of directors for the Council for Affordable Quality Healthcare, an alliance of the nation’s leading health plans. He also chairs the Research Triangle Regional Partnership, serves on the board of North Carolina Chamber (executive committee) and chairs the board of trustees at East Carolina University. He has served on the board and executive committee of the Triangle United Way and will become chair in April 2008.
Greczyn earned a masters of public health from the University of North Carolina at Chapel Hill and a bachelor of arts in psychology from East Carolina University. He also completed the executive program in healthcare finance management at UNC-Chapel Hill.
Christopher A. Viehbacher
President, US Pharmaceuticals, GlaxoSmithKline
Chris Viehbacher has served as President of US Pharmaceuticals at GlaxoSmithKline (GSK) since January 2003. Previously he had been President of Pharmaceuticals Europe since January 2001. Viehbacher joined the GSK board of directors in January 2008.
Viehbacher joined the company when it was Wellcome GmbH, Germany in 1988 as Chief Financial Accountant and was promoted to Finance Director in 1989. From 1993 to 1995, he served as President and Chief Executive Officer of Burroughs Wellcome Inc., Canada. He joined Glaxo Wellcome France in 1995 as Vice President of Strategy and Integration, following a period based in London as a member of the coordination team during the Glaxo Wellcome integration. In 1996, he became General Manager of Glaxo Wellcome France, and the following year was promoted to Chairman and Managing Director.
In 2002, Viehbacher served as one of two industry representatives on the G10 High Level Working Group sponsored by the European Commission to restore the competitiveness of the EU pharmaceutical industry. And in 2003, France recognized Viehbacher with its prestigious Légion d'Honneur award for his contributions to business and healthcare.
Viehbacher currently resides in Raleigh, North Carolina, with his wife Alison and their three children. He is a board member of PhRMA, the CEO Roundtable on Cancer, Research!America, North Carolina Chamber, North Carolina GlaxoSmithKline Foundation, Triangle United Way and the Cardinal Club.
Robert R. Waller, MD
Chair, Board of Directors, Institute for Healthcare Improvement; past President and CEO of Mayo Clinic, Mayo Foundation
An ophthalmologist by training, Dr. Robert Waller served on Mayo Foundation’s Board of Trustees from 1978 through 1998 and as President and CEO of Mayo Clinic/Mayo Foundation from 1988 to 1998. He was named President Emeritus in January 1999. Dr. Waller has been Professor of Ophthalmology at Mayo College of Medicine, where he chaired the Department of Ophthalmology from 1974 to 1984.
Dr. Waller has served many professional groups, including the American Board of Ophthalmology (Director and Chair), American Ophthalmological Society, the Healthcare Leadership Council (Chair Emeritus) and InterStudy (Chair). He was also a member of the Bush-Cheney Transition Advisory Committee for Health and Human Services and the National Advisory Council for the Agency for Healthcare Research and Quality.
Dr. Waller is a graduate of Duke University and the University of Tennessee, where he was named Distinguished Alumnus. He obtained residency training in internal medicine and ophthalmology at the Mayo Graduate School of Medicine and fellowship training in oculo-plastic surgery at the University of California, San Francisco.
Dr. Waller rejoined the board of directors of the Institute for Healthcare Improvement for a second term in 2004 and currently serves as Chair of that board. Additionally, Dr. Waller is on the board of directors of the Howard Baker School of Public Policy at the University of Tennessee; he is a trustee of Rhodes College; and he serves on the board of the Church Health Center in Memphis.
Sponsor:
